SARS-CoV-2 vaccines and myocarditis

被引：4
|
作者：
Sularz, Agata Katarzyna [1 ]
Hua, Alina [1 ]
Ismail, Tevfik [2 ,3 ]
机构：
[1] Guys & St Thomas NHS Fdn Trust, St Thomas Hosp, London, England
[2] Kings Coll London, London, England
[3] Kings Coll London, London WC2R 2LS, England
来源：
CLINICAL MEDICINE | 2023年 / 23卷 / 05期
关键词：
SARS-CoV-2 vaccine-related myocarditis; mRNA vaccine; vaccine safety; COVID-19; myocarditis; MESSENGER-RNA VACCINATION; UNITED-STATES; COVID-19; VACCINATION; YOUNG-ADULTS; ADOLESCENTS; DIAGNOSIS; ETIOLOGY; CHILDREN;
D O I：
10.7861/clinmed.2023-0049
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The development of safe and effective vaccines against severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) was a major turning point in the fight against the Coronavirus 2019 (COVID-19) pandemic. However, pharmacovigilance has revealed a small but significant incidence of cardiac inflammation manifesting clinically as myocarditis or pericarditis, particularly in younger vaccine recipients. The incidence is the highest among men under age 40 within a week of receiving the second dose of the mRNA vaccine. In this review, we summarise the evidence for, and guidelines in relation to, SARS-CoV2 vaccine-related myocarditis.
引用
收藏
页码：495 / 502
页数：8
相关论文
共 50 条
  • [1] Myocarditis Following SARS-CoV-2 Vaccines: A Series of Six Cases
    Ferchichi, K.
    Aouniti, I.
    Zaiem, A.
    Zgolli, F.
    Daghfous, R.
    Aidli, S. E.
    [J]. DRUG SAFETY, 2022, 45 (10) : 1238 - 1238
  • [2] SARS-CoV-2 Vaccines
    Creech, C. Buddy
    Walker, Shannon C.
    Samuels, Robert J.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 325 (13): : 1318 - 1320
  • [3] SARS-COV-2 INDUCED MYOCARDITIS
    Mikulic, Sebastian
    Kandah, Fadi
    Martinez, Andres
    Patel, Pujan
    [J]. CHEST, 2020, 158 (04) : 2580A - 2580A
  • [4] SARS-CoV-2 vaccines in development
    Krammer, Florian
    [J]. NATURE, 2020, 586 (7830) : 516 - 527
  • [5] SARS-CoV-2 Vaccines and the Skin
    Galvan-Casas, C.
    Catala, A.
    Munoz-Santos, C.
    [J]. ACTAS DERMO-SIFILIOGRAFICAS, 2021, 112 (09): : 828 - 836
  • [6] SARS-CoV-2 vaccines in development
    Florian Krammer
    [J]. Nature, 2020, 586 : 516 - 527
  • [7] SARS-CoV-2 Variants and Vaccines
    Krause, Philip R.
    Fleming, Thomas R.
    Longini, Ira M.
    Peto, Richard
    Briand, Sylvie
    Heymann, David L.
    Beral, Valerie
    Snape, Matthew D.
    Rees, Helen
    Ropero, Alba-Maria
    Balicer, Ran D.
    Cramer, Jakob P.
    Munoz-Fontela, Cesar
    Gruber, Marion
    Gaspar, Rogerio
    Singh, Jerome A.
    Subbarao, Kanta
    Van Kerkhove, Maria D.
    Swaminathan, Soumya
    Ryan, Michael J.
    Henao-Restrepo, Ana-Maria
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (02): : 179 - 186
  • [8] Nanocarrier vaccines for SARS-CoV-2
    Machhi, Jatin
    Shahjin, Farah
    Das, Srijanee
    Patel, Milankumar
    Abdelmoaty, Mai Mohamed
    Cohen, Jacob D.
    Singh, Preet Amol
    Baldi, Ashish
    Bajwa, Neha
    Kumar, Raj
    Vora, Lalit K.
    Patel, Tapan A.
    Oleynikov, Maxim D.
    Soni, Dhruvkumar
    Yeapuri, Pravin
    Mukadam, Insiya
    Chakraborty, Rajashree
    Saksena, Caroline G.
    Herskovitz, Jonathan
    Hasan, Mahmudul
    Oupicky, David
    Das, Suvarthi
    Donnelly, Ryan F.
    Hettie, Kenneth S.
    Chang, Linda
    Gendelman, Howard E.
    Kevadiya, Bhavesh D.
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2021, 171 : 215 - 239
  • [9] Development of SARS-CoV-2 vaccines
    Barajas-Nava, Leticia A.
    [J]. BOLETIN MEDICO DEL HOSPITAL INFANTIL DE MEXICO, 2021, 78 (01): : 66 - 74
  • [10] Autoimmune response after SARS-CoV-2 infection and SARS-CoV-2 vaccines
    Hromic-Jahjefendic, Altijana
    Lundstrom, Kenneth
    Adilovic, Muhamed
    Aljabali, Alaa A. A.
    Tambuwala, Murtaza M.
    Serrano-Aroca, Angel
    Uversky, Vladimir N.
    [J]. AUTOIMMUNITY REVIEWS, 2024, 23 (03)
12345